Incidence and predictors of mortality among HIV positive children on anti-retroviral therapy in the selected health facilities of West Wollega Zone, Western Ethiopia: Retrospective cohort study.

<h4>Introduction</h4>The mortality rate among Human immunodeficiency Virus (HIV) who have started antiretroviral therapy (ART) continues to be increased in resource-limited countries, despite a decline in developed nations. Furthermore, research within this age group is limited and has n...

Full description

Saved in:
Bibliographic Details
Main Authors: Gelane Gurmu, Emiru Merdassa, Gemechu Tiruneh, Keneni Efrem, Firezer Belay, Lalisa Mekonnen, Jira Wakoya Feyisa, Matiyos Lema, Adisu Tafari Shama, Markos Desalegn
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0314112
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540176198402048
author Gelane Gurmu
Emiru Merdassa
Gemechu Tiruneh
Keneni Efrem
Firezer Belay
Lalisa Mekonnen
Jira Wakoya Feyisa
Matiyos Lema
Adisu Tafari Shama
Markos Desalegn
author_facet Gelane Gurmu
Emiru Merdassa
Gemechu Tiruneh
Keneni Efrem
Firezer Belay
Lalisa Mekonnen
Jira Wakoya Feyisa
Matiyos Lema
Adisu Tafari Shama
Markos Desalegn
author_sort Gelane Gurmu
collection DOAJ
description <h4>Introduction</h4>The mortality rate among Human immunodeficiency Virus (HIV) who have started antiretroviral therapy (ART) continues to be increased in resource-limited countries, despite a decline in developed nations. Furthermore, research within this age group is limited and has not previously been conducted in the study area. Consequently, this study aimed to determine the incidence of mortality and its predictors among HIV-positive children who have been receiving ART at public health facilities in West Wollega.<h4>Objective</h4>To assess incidence rate and predictors of mortality among HIV-positive children on ART at selected health facilities of West Wollega, Ethiopia, 2022.<h4>Methods</h4>A retrospective cohort study design was conducted. A simple random sampling method was employed to select 286 children living with HIV who started ART from 01 January 2012 to 31 October 2021. Data were entered into Epi-Data Version 3.1, and STATA Version 14 was used for statistical analysis. A Kaplan-Meir survival curve and Long Rank test were used to estimate survival probability and assess statistical differences. The Cox regression model was used to determine independent predictors of mortality.<h4>Results</h4>The total follow-up time was 15, 652 child-months, and the overall incidence of mortality was 1.92 (95%CI: 1.34, 2.74) per 1000 child-months. The median time to death following the initiation of ART was 6 months. This study also showed that children with WHO clinical stage III (AHR = 3.4, 95% CI: 1.2, 7.4), stage IV (AHR = 5.4, 95%CI: 1.5, 19.8), Being anemic (AHR = 4.9, 95%CI: 1.8, 13.4), CD4 cell count below threshold (AHR = 3.7, 95%CI = 1.4, 9.5), delayed developmental milestone (AHR = 4.5, 95%CI: 1.7, 11.7) were at higher risk of mortality.<h4>Conclusion</h4>The overall mortality rate was lower compared to the previous study findings. Anemia, WHO clinical stage, CD4 cell count, and delayed developmental milestones were independent predictors of mortality. Therefore, the focus should be given to all children on ART during the early periods of ART initiation, advanced HIV disease, presence of anemia, severe immune deficiency, and delayed developmental milestones.
format Article
id doaj-art-48cba0a0cc8549a6a4059be7f9c06bf1
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-48cba0a0cc8549a6a4059be7f9c06bf12025-02-05T05:32:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201e031411210.1371/journal.pone.0314112Incidence and predictors of mortality among HIV positive children on anti-retroviral therapy in the selected health facilities of West Wollega Zone, Western Ethiopia: Retrospective cohort study.Gelane GurmuEmiru MerdassaGemechu TirunehKeneni EfremFirezer BelayLalisa MekonnenJira Wakoya FeyisaMatiyos LemaAdisu Tafari ShamaMarkos Desalegn<h4>Introduction</h4>The mortality rate among Human immunodeficiency Virus (HIV) who have started antiretroviral therapy (ART) continues to be increased in resource-limited countries, despite a decline in developed nations. Furthermore, research within this age group is limited and has not previously been conducted in the study area. Consequently, this study aimed to determine the incidence of mortality and its predictors among HIV-positive children who have been receiving ART at public health facilities in West Wollega.<h4>Objective</h4>To assess incidence rate and predictors of mortality among HIV-positive children on ART at selected health facilities of West Wollega, Ethiopia, 2022.<h4>Methods</h4>A retrospective cohort study design was conducted. A simple random sampling method was employed to select 286 children living with HIV who started ART from 01 January 2012 to 31 October 2021. Data were entered into Epi-Data Version 3.1, and STATA Version 14 was used for statistical analysis. A Kaplan-Meir survival curve and Long Rank test were used to estimate survival probability and assess statistical differences. The Cox regression model was used to determine independent predictors of mortality.<h4>Results</h4>The total follow-up time was 15, 652 child-months, and the overall incidence of mortality was 1.92 (95%CI: 1.34, 2.74) per 1000 child-months. The median time to death following the initiation of ART was 6 months. This study also showed that children with WHO clinical stage III (AHR = 3.4, 95% CI: 1.2, 7.4), stage IV (AHR = 5.4, 95%CI: 1.5, 19.8), Being anemic (AHR = 4.9, 95%CI: 1.8, 13.4), CD4 cell count below threshold (AHR = 3.7, 95%CI = 1.4, 9.5), delayed developmental milestone (AHR = 4.5, 95%CI: 1.7, 11.7) were at higher risk of mortality.<h4>Conclusion</h4>The overall mortality rate was lower compared to the previous study findings. Anemia, WHO clinical stage, CD4 cell count, and delayed developmental milestones were independent predictors of mortality. Therefore, the focus should be given to all children on ART during the early periods of ART initiation, advanced HIV disease, presence of anemia, severe immune deficiency, and delayed developmental milestones.https://doi.org/10.1371/journal.pone.0314112
spellingShingle Gelane Gurmu
Emiru Merdassa
Gemechu Tiruneh
Keneni Efrem
Firezer Belay
Lalisa Mekonnen
Jira Wakoya Feyisa
Matiyos Lema
Adisu Tafari Shama
Markos Desalegn
Incidence and predictors of mortality among HIV positive children on anti-retroviral therapy in the selected health facilities of West Wollega Zone, Western Ethiopia: Retrospective cohort study.
PLoS ONE
title Incidence and predictors of mortality among HIV positive children on anti-retroviral therapy in the selected health facilities of West Wollega Zone, Western Ethiopia: Retrospective cohort study.
title_full Incidence and predictors of mortality among HIV positive children on anti-retroviral therapy in the selected health facilities of West Wollega Zone, Western Ethiopia: Retrospective cohort study.
title_fullStr Incidence and predictors of mortality among HIV positive children on anti-retroviral therapy in the selected health facilities of West Wollega Zone, Western Ethiopia: Retrospective cohort study.
title_full_unstemmed Incidence and predictors of mortality among HIV positive children on anti-retroviral therapy in the selected health facilities of West Wollega Zone, Western Ethiopia: Retrospective cohort study.
title_short Incidence and predictors of mortality among HIV positive children on anti-retroviral therapy in the selected health facilities of West Wollega Zone, Western Ethiopia: Retrospective cohort study.
title_sort incidence and predictors of mortality among hiv positive children on anti retroviral therapy in the selected health facilities of west wollega zone western ethiopia retrospective cohort study
url https://doi.org/10.1371/journal.pone.0314112
work_keys_str_mv AT gelanegurmu incidenceandpredictorsofmortalityamonghivpositivechildrenonantiretroviraltherapyintheselectedhealthfacilitiesofwestwollegazonewesternethiopiaretrospectivecohortstudy
AT emirumerdassa incidenceandpredictorsofmortalityamonghivpositivechildrenonantiretroviraltherapyintheselectedhealthfacilitiesofwestwollegazonewesternethiopiaretrospectivecohortstudy
AT gemechutiruneh incidenceandpredictorsofmortalityamonghivpositivechildrenonantiretroviraltherapyintheselectedhealthfacilitiesofwestwollegazonewesternethiopiaretrospectivecohortstudy
AT keneniefrem incidenceandpredictorsofmortalityamonghivpositivechildrenonantiretroviraltherapyintheselectedhealthfacilitiesofwestwollegazonewesternethiopiaretrospectivecohortstudy
AT firezerbelay incidenceandpredictorsofmortalityamonghivpositivechildrenonantiretroviraltherapyintheselectedhealthfacilitiesofwestwollegazonewesternethiopiaretrospectivecohortstudy
AT lalisamekonnen incidenceandpredictorsofmortalityamonghivpositivechildrenonantiretroviraltherapyintheselectedhealthfacilitiesofwestwollegazonewesternethiopiaretrospectivecohortstudy
AT jirawakoyafeyisa incidenceandpredictorsofmortalityamonghivpositivechildrenonantiretroviraltherapyintheselectedhealthfacilitiesofwestwollegazonewesternethiopiaretrospectivecohortstudy
AT matiyoslema incidenceandpredictorsofmortalityamonghivpositivechildrenonantiretroviraltherapyintheselectedhealthfacilitiesofwestwollegazonewesternethiopiaretrospectivecohortstudy
AT adisutafarishama incidenceandpredictorsofmortalityamonghivpositivechildrenonantiretroviraltherapyintheselectedhealthfacilitiesofwestwollegazonewesternethiopiaretrospectivecohortstudy
AT markosdesalegn incidenceandpredictorsofmortalityamonghivpositivechildrenonantiretroviraltherapyintheselectedhealthfacilitiesofwestwollegazonewesternethiopiaretrospectivecohortstudy